Log In
BCIQ
Print this Print this
 

miR-002

  Manage Alerts
Collapse Summary General Information
Company TAmiRNA GmbH
DescriptionMicroRNA targeting miR-002
Molecular Target
Mechanism of Action 
Therapeutic ModalityNucleic acid: Linear RNA: microRNA
Latest Stage of DevelopmentDiscovery
Standard IndicationOsteoporosis
Indication DetailsTreat osteoporosis
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today